nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobutrol—Urine abnormality—Mitoxantrone—sarcoma	0.0371	0.0371	CcSEcCtD
Gadobutrol—Urine analysis abnormal—Mitoxantrone—sarcoma	0.0349	0.0349	CcSEcCtD
Gadobutrol—Injection site pain—Thiotepa—sarcoma	0.0291	0.0291	CcSEcCtD
Gadobutrol—Urine abnormality—Epirubicin—sarcoma	0.0173	0.0173	CcSEcCtD
Gadobutrol—Urine analysis abnormal—Epirubicin—sarcoma	0.0163	0.0163	CcSEcCtD
Gadobutrol—Urine abnormality—Doxorubicin—sarcoma	0.016	0.016	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Mitoxantrone—sarcoma	0.0154	0.0154	CcSEcCtD
Gadobutrol—Urine analysis abnormal—Doxorubicin—sarcoma	0.0151	0.0151	CcSEcCtD
Gadobutrol—Parosmia—Epirubicin—sarcoma	0.0148	0.0148	CcSEcCtD
Gadobutrol—Parosmia—Doxorubicin—sarcoma	0.0137	0.0137	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Etoposide—sarcoma	0.0128	0.0128	CcSEcCtD
Gadobutrol—Sweating increased—Mitoxantrone—sarcoma	0.0125	0.0125	CcSEcCtD
Gadobutrol—Injection site pain—Epirubicin—sarcoma	0.0117	0.0117	CcSEcCtD
Gadobutrol—Injection site pain—Doxorubicin—sarcoma	0.0108	0.0108	CcSEcCtD
Gadobutrol—Hypoaesthesia—Vincristine—sarcoma	0.0105	0.0105	CcSEcCtD
Gadobutrol—Sweating increased—Etoposide—sarcoma	0.0104	0.0104	CcSEcCtD
Gadobutrol—Convulsion—Thiotepa—sarcoma	0.009	0.009	CcSEcCtD
Gadobutrol—Dysgeusia—Mitoxantrone—sarcoma	0.00879	0.00879	CcSEcCtD
Gadobutrol—Hypoaesthesia—Etoposide—sarcoma	0.00853	0.00853	CcSEcCtD
Gadobutrol—Infection—Thiotepa—sarcoma	0.00842	0.00842	CcSEcCtD
Gadobutrol—Infection—Dactinomycin—sarcoma	0.00836	0.00836	CcSEcCtD
Gadobutrol—Abnormal vision—Epirubicin—sarcoma	0.00835	0.00835	CcSEcCtD
Gadobutrol—Vertigo—Vincristine—sarcoma	0.00828	0.00828	CcSEcCtD
Gadobutrol—Convulsion—Vincristine—sarcoma	0.00798	0.00798	CcSEcCtD
Gadobutrol—Convulsion—Mitoxantrone—sarcoma	0.00777	0.00777	CcSEcCtD
Gadobutrol—Abnormal vision—Doxorubicin—sarcoma	0.00772	0.00772	CcSEcCtD
Gadobutrol—Paraesthesia—Thiotepa—sarcoma	0.00761	0.00761	CcSEcCtD
Gadobutrol—Anaphylactic shock—Vincristine—sarcoma	0.00752	0.00752	CcSEcCtD
Gadobutrol—Infection—Vincristine—sarcoma	0.00747	0.00747	CcSEcCtD
Gadobutrol—Hot flush—Epirubicin—sarcoma	0.00743	0.00743	CcSEcCtD
Gadobutrol—Menopausal symptoms—Epirubicin—sarcoma	0.00736	0.00736	CcSEcCtD
Gadobutrol—Anaphylactic shock—Mitoxantrone—sarcoma	0.00732	0.00732	CcSEcCtD
Gadobutrol—Dysgeusia—Etoposide—sarcoma	0.00731	0.00731	CcSEcCtD
Gadobutrol—Infection—Mitoxantrone—sarcoma	0.00728	0.00728	CcSEcCtD
Gadobutrol—Hyperhidrosis—Vincristine—sarcoma	0.00727	0.00727	CcSEcCtD
Gadobutrol—Pain—Thiotepa—sarcoma	0.00725	0.00725	CcSEcCtD
Gadobutrol—Pain—Dactinomycin—sarcoma	0.0072	0.0072	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Epirubicin—sarcoma	0.00718	0.00718	CcSEcCtD
Gadobutrol—Hyperhidrosis—Mitoxantrone—sarcoma	0.00708	0.00708	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Thiotepa—sarcoma	0.00693	0.00693	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Dactinomycin—sarcoma	0.00688	0.00688	CcSEcCtD
Gadobutrol—Hot flush—Doxorubicin—sarcoma	0.00687	0.00687	CcSEcCtD
Gadobutrol—Menopausal symptoms—Doxorubicin—sarcoma	0.00681	0.00681	CcSEcCtD
Gadobutrol—Insomnia—Vincristine—sarcoma	0.0068	0.0068	CcSEcCtD
Gadobutrol—Paraesthesia—Vincristine—sarcoma	0.00675	0.00675	CcSEcCtD
Gadobutrol—Vertigo—Etoposide—sarcoma	0.00671	0.00671	CcSEcCtD
Gadobutrol—Body temperature increased—Thiotepa—sarcoma	0.0067	0.0067	CcSEcCtD
Gadobutrol—Abdominal pain—Thiotepa—sarcoma	0.0067	0.0067	CcSEcCtD
Gadobutrol—Body temperature increased—Dactinomycin—sarcoma	0.00665	0.00665	CcSEcCtD
Gadobutrol—Abdominal pain—Dactinomycin—sarcoma	0.00665	0.00665	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Doxorubicin—sarcoma	0.00664	0.00664	CcSEcCtD
Gadobutrol—Paraesthesia—Mitoxantrone—sarcoma	0.00658	0.00658	CcSEcCtD
Gadobutrol—Dyspnoea—Mitoxantrone—sarcoma	0.00653	0.00653	CcSEcCtD
Gadobutrol—Convulsion—Etoposide—sarcoma	0.00647	0.00647	CcSEcCtD
Gadobutrol—Pain—Vincristine—sarcoma	0.00643	0.00643	CcSEcCtD
Gadobutrol—Orthostatic hypotension—Epirubicin—sarcoma	0.00634	0.00634	CcSEcCtD
Gadobutrol—Pain—Mitoxantrone—sarcoma	0.00626	0.00626	CcSEcCtD
Gadobutrol—Hypersensitivity—Thiotepa—sarcoma	0.00625	0.00625	CcSEcCtD
Gadobutrol—Hypersensitivity—Dactinomycin—sarcoma	0.0062	0.0062	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Vincristine—sarcoma	0.00615	0.00615	CcSEcCtD
Gadobutrol—Anaphylactic shock—Etoposide—sarcoma	0.00609	0.00609	CcSEcCtD
Gadobutrol—Infection—Etoposide—sarcoma	0.00605	0.00605	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00599	0.00599	CcSEcCtD
Gadobutrol—Abdominal pain—Vincristine—sarcoma	0.00594	0.00594	CcSEcCtD
Gadobutrol—Body temperature increased—Vincristine—sarcoma	0.00594	0.00594	CcSEcCtD
Gadobutrol—Hyperhidrosis—Etoposide—sarcoma	0.00589	0.00589	CcSEcCtD
Gadobutrol—Orthostatic hypotension—Doxorubicin—sarcoma	0.00587	0.00587	CcSEcCtD
Gadobutrol—Diarrhoea—Thiotepa—sarcoma	0.0058	0.0058	CcSEcCtD
Gadobutrol—Abdominal pain—Mitoxantrone—sarcoma	0.00579	0.00579	CcSEcCtD
Gadobutrol—Body temperature increased—Mitoxantrone—sarcoma	0.00579	0.00579	CcSEcCtD
Gadobutrol—Diarrhoea—Dactinomycin—sarcoma	0.00576	0.00576	CcSEcCtD
Gadobutrol—Dizziness—Thiotepa—sarcoma	0.00561	0.00561	CcSEcCtD
Gadobutrol—Pollakiuria—Epirubicin—sarcoma	0.00555	0.00555	CcSEcCtD
Gadobutrol—Hypersensitivity—Vincristine—sarcoma	0.00554	0.00554	CcSEcCtD
Gadobutrol—Paraesthesia—Etoposide—sarcoma	0.00547	0.00547	CcSEcCtD
Gadobutrol—Dyspnoea—Etoposide—sarcoma	0.00543	0.00543	CcSEcCtD
Gadobutrol—Hypersensitivity—Mitoxantrone—sarcoma	0.0054	0.0054	CcSEcCtD
Gadobutrol—Vomiting—Thiotepa—sarcoma	0.00539	0.00539	CcSEcCtD
Gadobutrol—Vomiting—Dactinomycin—sarcoma	0.00535	0.00535	CcSEcCtD
Gadobutrol—Rash—Thiotepa—sarcoma	0.00535	0.00535	CcSEcCtD
Gadobutrol—Dermatitis—Thiotepa—sarcoma	0.00534	0.00534	CcSEcCtD
Gadobutrol—Headache—Thiotepa—sarcoma	0.00531	0.00531	CcSEcCtD
Gadobutrol—Rash—Dactinomycin—sarcoma	0.00531	0.00531	CcSEcCtD
Gadobutrol—Pain—Etoposide—sarcoma	0.00521	0.00521	CcSEcCtD
Gadobutrol—Diarrhoea—Vincristine—sarcoma	0.00514	0.00514	CcSEcCtD
Gadobutrol—Pollakiuria—Doxorubicin—sarcoma	0.00513	0.00513	CcSEcCtD
Gadobutrol—Nausea—Thiotepa—sarcoma	0.00504	0.00504	CcSEcCtD
Gadobutrol—Diarrhoea—Mitoxantrone—sarcoma	0.00501	0.00501	CcSEcCtD
Gadobutrol—Nausea—Dactinomycin—sarcoma	0.005	0.005	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Etoposide—sarcoma	0.00498	0.00498	CcSEcCtD
Gadobutrol—Dizziness—Vincristine—sarcoma	0.00497	0.00497	CcSEcCtD
Gadobutrol—Abdominal pain—Etoposide—sarcoma	0.00482	0.00482	CcSEcCtD
Gadobutrol—Body temperature increased—Etoposide—sarcoma	0.00482	0.00482	CcSEcCtD
Gadobutrol—Hypoaesthesia—Epirubicin—sarcoma	0.00478	0.00478	CcSEcCtD
Gadobutrol—Vomiting—Vincristine—sarcoma	0.00478	0.00478	CcSEcCtD
Gadobutrol—Rash—Vincristine—sarcoma	0.00474	0.00474	CcSEcCtD
Gadobutrol—Dermatitis—Vincristine—sarcoma	0.00474	0.00474	CcSEcCtD
Gadobutrol—Headache—Vincristine—sarcoma	0.00471	0.00471	CcSEcCtD
Gadobutrol—Vomiting—Mitoxantrone—sarcoma	0.00466	0.00466	CcSEcCtD
Gadobutrol—Visual impairment—Epirubicin—sarcoma	0.00463	0.00463	CcSEcCtD
Gadobutrol—Rash—Mitoxantrone—sarcoma	0.00462	0.00462	CcSEcCtD
Gadobutrol—Dermatitis—Mitoxantrone—sarcoma	0.00461	0.00461	CcSEcCtD
Gadobutrol—Headache—Mitoxantrone—sarcoma	0.00459	0.00459	CcSEcCtD
Gadobutrol—Hypersensitivity—Etoposide—sarcoma	0.00449	0.00449	CcSEcCtD
Gadobutrol—Nausea—Vincristine—sarcoma	0.00447	0.00447	CcSEcCtD
Gadobutrol—Hypoaesthesia—Doxorubicin—sarcoma	0.00442	0.00442	CcSEcCtD
Gadobutrol—Nausea—Mitoxantrone—sarcoma	0.00435	0.00435	CcSEcCtD
Gadobutrol—Visual impairment—Doxorubicin—sarcoma	0.00429	0.00429	CcSEcCtD
Gadobutrol—Diarrhoea—Etoposide—sarcoma	0.00417	0.00417	CcSEcCtD
Gadobutrol—Dysgeusia—Epirubicin—sarcoma	0.0041	0.0041	CcSEcCtD
Gadobutrol—Dizziness—Etoposide—sarcoma	0.00403	0.00403	CcSEcCtD
Gadobutrol—Vomiting—Etoposide—sarcoma	0.00387	0.00387	CcSEcCtD
Gadobutrol—Rash—Etoposide—sarcoma	0.00384	0.00384	CcSEcCtD
Gadobutrol—Dermatitis—Etoposide—sarcoma	0.00384	0.00384	CcSEcCtD
Gadobutrol—Headache—Etoposide—sarcoma	0.00382	0.00382	CcSEcCtD
Gadobutrol—Dysgeusia—Doxorubicin—sarcoma	0.00379	0.00379	CcSEcCtD
Gadobutrol—Vertigo—Epirubicin—sarcoma	0.00376	0.00376	CcSEcCtD
Gadobutrol—Palpitations—Epirubicin—sarcoma	0.0037	0.0037	CcSEcCtD
Gadobutrol—Convulsion—Epirubicin—sarcoma	0.00362	0.00362	CcSEcCtD
Gadobutrol—Nausea—Etoposide—sarcoma	0.00362	0.00362	CcSEcCtD
Gadobutrol—Dry mouth—Epirubicin—sarcoma	0.00348	0.00348	CcSEcCtD
Gadobutrol—Vertigo—Doxorubicin—sarcoma	0.00348	0.00348	CcSEcCtD
Gadobutrol—Palpitations—Doxorubicin—sarcoma	0.00342	0.00342	CcSEcCtD
Gadobutrol—Anaphylactic shock—Epirubicin—sarcoma	0.00341	0.00341	CcSEcCtD
Gadobutrol—Infection—Epirubicin—sarcoma	0.00339	0.00339	CcSEcCtD
Gadobutrol—Convulsion—Doxorubicin—sarcoma	0.00335	0.00335	CcSEcCtD
Gadobutrol—Hyperhidrosis—Epirubicin—sarcoma	0.0033	0.0033	CcSEcCtD
Gadobutrol—Dry mouth—Doxorubicin—sarcoma	0.00322	0.00322	CcSEcCtD
Gadobutrol—Anaphylactic shock—Doxorubicin—sarcoma	0.00316	0.00316	CcSEcCtD
Gadobutrol—Infection—Doxorubicin—sarcoma	0.00314	0.00314	CcSEcCtD
Gadobutrol—Insomnia—Epirubicin—sarcoma	0.00309	0.00309	CcSEcCtD
Gadobutrol—Paraesthesia—Epirubicin—sarcoma	0.00307	0.00307	CcSEcCtD
Gadobutrol—Hyperhidrosis—Doxorubicin—sarcoma	0.00305	0.00305	CcSEcCtD
Gadobutrol—Dyspnoea—Epirubicin—sarcoma	0.00304	0.00304	CcSEcCtD
Gadobutrol—Pain—Epirubicin—sarcoma	0.00292	0.00292	CcSEcCtD
Gadobutrol—Insomnia—Doxorubicin—sarcoma	0.00286	0.00286	CcSEcCtD
Gadobutrol—Paraesthesia—Doxorubicin—sarcoma	0.00284	0.00284	CcSEcCtD
Gadobutrol—Dyspnoea—Doxorubicin—sarcoma	0.00282	0.00282	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Epirubicin—sarcoma	0.00279	0.00279	CcSEcCtD
Gadobutrol—Pain—Doxorubicin—sarcoma	0.0027	0.0027	CcSEcCtD
Gadobutrol—Body temperature increased—Epirubicin—sarcoma	0.0027	0.0027	CcSEcCtD
Gadobutrol—Abdominal pain—Epirubicin—sarcoma	0.0027	0.0027	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Doxorubicin—sarcoma	0.00258	0.00258	CcSEcCtD
Gadobutrol—Hypersensitivity—Epirubicin—sarcoma	0.00252	0.00252	CcSEcCtD
Gadobutrol—Abdominal pain—Doxorubicin—sarcoma	0.0025	0.0025	CcSEcCtD
Gadobutrol—Body temperature increased—Doxorubicin—sarcoma	0.0025	0.0025	CcSEcCtD
Gadobutrol—Diarrhoea—Epirubicin—sarcoma	0.00234	0.00234	CcSEcCtD
Gadobutrol—Hypersensitivity—Doxorubicin—sarcoma	0.00233	0.00233	CcSEcCtD
Gadobutrol—Dizziness—Epirubicin—sarcoma	0.00226	0.00226	CcSEcCtD
Gadobutrol—Vomiting—Epirubicin—sarcoma	0.00217	0.00217	CcSEcCtD
Gadobutrol—Diarrhoea—Doxorubicin—sarcoma	0.00216	0.00216	CcSEcCtD
Gadobutrol—Rash—Epirubicin—sarcoma	0.00215	0.00215	CcSEcCtD
Gadobutrol—Dermatitis—Epirubicin—sarcoma	0.00215	0.00215	CcSEcCtD
Gadobutrol—Headache—Epirubicin—sarcoma	0.00214	0.00214	CcSEcCtD
Gadobutrol—Dizziness—Doxorubicin—sarcoma	0.00209	0.00209	CcSEcCtD
Gadobutrol—Nausea—Epirubicin—sarcoma	0.00203	0.00203	CcSEcCtD
Gadobutrol—Vomiting—Doxorubicin—sarcoma	0.00201	0.00201	CcSEcCtD
Gadobutrol—Rash—Doxorubicin—sarcoma	0.00199	0.00199	CcSEcCtD
Gadobutrol—Dermatitis—Doxorubicin—sarcoma	0.00199	0.00199	CcSEcCtD
Gadobutrol—Headache—Doxorubicin—sarcoma	0.00198	0.00198	CcSEcCtD
Gadobutrol—Nausea—Doxorubicin—sarcoma	0.00188	0.00188	CcSEcCtD
